Business Context and Reporting Period
Tonix Pharmaceuticals Holding Corp. (TNXP) filed a Form 8-K Current Report on March 16, 2026. The filing discloses a change in the company's independent registered public accounting firm.
Key Financial Metrics
This filing does not contain specific revenue, profit, cash flow, margin, debt, or liquidity figures. However, it references prior audit reports for the fiscal years ended December 31, 2025, and December 31, 2024, which included an explanatory paragraph regarding the company's continuing losses and negative cash flows from operating activities. These conditions raised substantial doubt about the company's ability to continue as a going concern.
Material Changes
- Dismissal of Auditor: On March 16, 2026, the company dismissed EisnerAmper LLP as its independent registered public accounting firm.
- Engagement of New Auditor: On March 16, 2026, the company appointed PricewaterhouseCoopers LLP (PwC) as its new independent registered public accounting firm for the year ending December 31, 2026, and related interim periods.
- Reason for Change: The dismissal of EisnerAmper was not related to any disagreements on accounting principles, financial statement disclosure, or auditing scope. Previously identified material weaknesses in internal controls (related to non-routine transactions, inventory realizability, and warrant amendments) were remediated by the year ended December 31, 2024, and did not result in restatements.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or new risk factors beyond the historical context of going concern doubts noted in prior audits. The company confirmed that no "reportable events" or disagreements occurred with the outgoing auditor during the two most recent fiscal years or the interim period leading up to the dismissal.
Investor Verification Checklist
- Verify the letter from EisnerAmper LLP (Exhibit 16.01) confirming no disagreements with the company's disclosures.
- Review the most recent Form 10-K or 10-Q to assess the current status of the "going concern" warning and negative cash flows.
- Confirm the timeline for PwC's initial audit scope and any potential impact on future financial reporting schedules.
- Check for any subsequent filings regarding the remediation of internal controls to ensure no new material weaknesses have emerged.